Jim Cramer recently hyped up one of his guests in advance of his CNBC show "Mad Money," posting on X that people "will be very interested in MindMed for certain . LSD," and he made sure his interview did not disappoint. Mind Medicine Inc. (NASDAQ:MNMD) sees a massive market opportunity ahead, citing 21% of U.S. adults with an anxiety disorder, an estimated 4.4% of U.S. adults with attention-deficit/hyperactivity disorder (ADHD) and a $461 billion economic cost from autism spectrum disorder by
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report)’s share price traded up 7.3% during trading on Wednesday . The company traded as high as $10.93 and last traded at $10.78. 988,045 shares changed hands during trading, a decline of 50% from the average session volume of 1,992,814 shares. The stock had previously closed at […]
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) shares traded up 7.3% during mid-day trading on Wednesday . The stock traded as high as $10.93 and last traded at $10.78. 988,045 shares were traded during trading, a decline of 50% from the average session volume of 1,992,814 shares. The stock had previously closed at […]
Explore the latest market trends covering MindMed's CEO interview, SPDR Gold Shares rally pause, and Costco's technical analysis near $700 support. Gain insights into potential price movements and key indicators affecting these stocks in this comprehensive market update.
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up to $11 75 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.